HEADER STRUCTURAL PROTEIN/INHIBITOR 28-JUN-22 7YAZ TITLE CRYSTAL STRUCTURE OF ZAK IN COMPLEX WITH COMPOUND YH-186 CAVEAT 7YAZ IGV A 401 HAS WRONG CHIRALITY AT ATOM C25 COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE MLT; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: ZAK; COMPND 5 EC: 2.7.11.25; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ZAK; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS ZAK, INHIBITOR, YH-186, STRUCTURAL PROTEIN, STRUCTURAL PROTEIN- KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR L.L.KONG,C.H.YUN REVDAT 1 09-AUG-23 7YAZ 0 JRNL AUTH Y.ZHOU,H.YU,A.C.VIND,L.KONG,Y.LIU,X.SONG,Z.TU,C.YUN, JRNL AUTH 2 J.B.SMAILL,Q.W.ZHANG,K.DING,S.BEKKER-JENSEN,X.LU JRNL TITL RATIONAL DESIGN OF COVALENT KINASE INHIBITORS BY AN JRNL TITL 2 INTEGRATED COMPUTATIONAL WORKFLOW (KIN-COV). JRNL REF J.MED.CHEM. V. 66 7405 2023 JRNL REFN ISSN 0022-2623 JRNL PMID 37220641 JRNL DOI 10.1021/ACS.JMEDCHEM.3C00088 REMARK 2 REMARK 2 RESOLUTION. 2.54 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.19.2_4158 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.54 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 31.27 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.380 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 3 NUMBER OF REFLECTIONS : 8564 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.187 REMARK 3 R VALUE (WORKING SET) : 0.184 REMARK 3 FREE R VALUE : 0.252 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.480 REMARK 3 FREE R VALUE TEST SET COUNT : 384 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 4.3600 - 3.6600 0.99 2785 135 0.1681 0.2217 REMARK 3 2 3.6600 - 2.9100 1.00 2763 113 0.1938 0.2662 REMARK 3 3 2.9100 - 2.5400 0.97 2632 136 0.2147 0.3266 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.320 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 28.140 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 37.18 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 42.84 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7YAZ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 30-JUN-22. REMARK 100 THE DEPOSITION ID IS D_1300030581. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-JUN-21 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL19U1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97853 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 8584 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.540 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 17.00 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.55 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.64 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5X5O REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 33.31 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.84 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.05 M MAGNESIUM ACETATE, 0.05 M REMARK 280 SODIUM ACETATE PH 5.0, 28% PEG400, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 64.98800 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 24.30400 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 64.98800 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 24.30400 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 523 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 0 REMARK 465 ALA A 1 REMARK 465 MET A 2 REMARK 465 GLY A 3 REMARK 465 SER A 4 REMARK 465 GLY A 5 REMARK 465 ALA A 6 REMARK 465 SER A 7 REMARK 465 MET A 164 REMARK 465 ASP A 300 REMARK 465 LEU A 301 REMARK 465 SER A 302 REMARK 465 PHE A 303 REMARK 465 LYS A 304 REMARK 465 GLU A 305 REMARK 465 GLN A 306 REMARK 465 GLU A 307 REMARK 465 LEU A 308 REMARK 465 LYS A 309 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 HIS A 163 ND1 CE1 NE2 REMARK 470 SER A 165 OG REMARK 470 GLU A 210 CD OE1 OE2 REMARK 470 ARG A 233 NH1 NH2 REMARK 470 LYS A 296 CG CD CE NZ REMARK 470 LEU A 297 CG CD1 CD2 REMARK 470 ARG A 299 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O CYS A 22A N GLY A 23 1.11 REMARK 500 O CYS A 22A N GLY A 23 1.13 REMARK 500 C CYS A 22A CA GLY A 23 1.49 REMARK 500 C CYS A 22A CA GLY A 23 1.49 REMARK 500 CA CYS A 22A N GLY A 23 1.59 REMARK 500 CA CYS A 22A N GLY A 23 1.60 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O GLY A 23 OE2 GLU A 292 4545 1.95 REMARK 500 OG SER A 26 O GLN A 179 4546 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 CYS A 22A C GLY A 23 N -1.179 REMARK 500 CYS A 22A C GLY A 23 N -1.107 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 CYS A 22A O - C - N ANGL. DEV. = -65.2 DEGREES REMARK 500 CYS A 22A O - C - N ANGL. DEV. = -51.4 DEGREES REMARK 500 GLY A 23 C - N - CA ANGL. DEV. = -31.6 DEGREES REMARK 500 GLY A 23 C - N - CA ANGL. DEV. = -33.0 DEGREES REMARK 500 LEU A 48 CA - CB - CG ANGL. DEV. = 15.9 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 95 32.83 -91.98 REMARK 500 ARG A 132 -12.20 68.42 REMARK 500 PHE A 157 -67.05 -106.93 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 CYS A 22A GLY A 23 147.91 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 CYS A 22A 104.32 REMARK 500 CYS A 22A 85.82 REMARK 500 REMARK 500 REMARK: NULL DBREF 7YAZ A 5 309 UNP Q9NYL2 MLTK_HUMAN 5 309 SEQADV 7YAZ GLY A 0 UNP Q9NYL2 EXPRESSION TAG SEQADV 7YAZ ALA A 1 UNP Q9NYL2 EXPRESSION TAG SEQADV 7YAZ MET A 2 UNP Q9NYL2 EXPRESSION TAG SEQADV 7YAZ GLY A 3 UNP Q9NYL2 EXPRESSION TAG SEQADV 7YAZ SER A 4 UNP Q9NYL2 EXPRESSION TAG SEQRES 1 A 310 GLY ALA MET GLY SER GLY ALA SER PHE VAL GLN ILE LYS SEQRES 2 A 310 PHE ASP ASP LEU GLN PHE PHE GLU ASN CYS GLY GLY GLY SEQRES 3 A 310 SER PHE GLY SER VAL TYR ARG ALA LYS TRP ILE SER GLN SEQRES 4 A 310 ASP LYS GLU VAL ALA VAL LYS LYS LEU LEU LYS ILE GLU SEQRES 5 A 310 LYS GLU ALA GLU ILE LEU SER VAL LEU SER HIS ARG ASN SEQRES 6 A 310 ILE ILE GLN PHE TYR GLY VAL ILE LEU GLU PRO PRO ASN SEQRES 7 A 310 TYR GLY ILE VAL THR GLU TYR ALA SER LEU GLY SER LEU SEQRES 8 A 310 TYR ASP TYR ILE ASN SER ASN ARG SER GLU GLU MET ASP SEQRES 9 A 310 MET ASP HIS ILE MET THR TRP ALA THR ASP VAL ALA LYS SEQRES 10 A 310 GLY MET HIS TYR LEU HIS MET GLU ALA PRO VAL LYS VAL SEQRES 11 A 310 ILE HIS ARG ASP LEU LYS SER ARG ASN VAL VAL ILE ALA SEQRES 12 A 310 ALA ASP GLY VAL LEU LYS ILE CYS ASP PHE GLY ALA SER SEQRES 13 A 310 ARG PHE HIS ASN HIS THR THR HIS MET SER LEU VAL GLY SEQRES 14 A 310 THR PHE PRO TRP MET ALA PRO GLU VAL ILE GLN SER LEU SEQRES 15 A 310 PRO VAL SER GLU THR CYS ASP THR TYR SER TYR GLY VAL SEQRES 16 A 310 VAL LEU TRP GLU MET LEU THR ARG GLU VAL PRO PHE LYS SEQRES 17 A 310 GLY LEU GLU GLY LEU GLN VAL ALA TRP LEU VAL VAL GLU SEQRES 18 A 310 LYS ASN GLU ARG LEU THR ILE PRO SER SER CYS PRO ARG SEQRES 19 A 310 SER PHE ALA GLU LEU LEU HIS GLN CYS TRP GLU ALA ASP SEQRES 20 A 310 ALA LYS LYS ARG PRO SER PHE LYS GLN ILE ILE SER ILE SEQRES 21 A 310 LEU GLU SER MET SER ASN ASP THR SER LEU PRO ASP LYS SEQRES 22 A 310 CYS ASN SER PHE LEU HIS ASN LYS ALA GLU TRP ARG CYS SEQRES 23 A 310 GLU ILE GLU ALA THR LEU GLU ARG LEU LYS LYS LEU GLU SEQRES 24 A 310 ARG ASP LEU SER PHE LYS GLU GLN GLU LEU LYS HET IGV A 401 96 HETNAM IGV ~{N}-[2,4-BIS(FLUORANYL)-3-[4-[3-[(3~{S})-1- HETNAM 2 IGV PROPANOYLPYRROLIDIN-3-YL]OXY-1~{H}-PYRAZOLO[3,4- HETNAM 3 IGV B]PYRIDIN-5-YL]-1,2,3-TRIAZOL-1-YL]PHENYL]-3-PHENYL- HETNAM 4 IGV BENZENESULFONAMIDE FORMUL 2 IGV C33 H28 F2 N8 O4 S FORMUL 3 HOH *23(H2 O) HELIX 1 AA1 LYS A 12 ASP A 14 5 3 HELIX 2 AA2 GLU A 51 LEU A 60 5 10 HELIX 3 AA3 SER A 89 ASN A 95 1 7 HELIX 4 AA4 SER A 96 MET A 102 5 7 HELIX 5 AA5 ASP A 103 GLU A 124 1 22 HELIX 6 AA6 LYS A 135 ARG A 137 5 3 HELIX 7 AA7 THR A 169 MET A 173 5 5 HELIX 8 AA8 ALA A 174 GLN A 179 1 6 HELIX 9 AA9 THR A 186 ARG A 202 1 17 HELIX 10 AB1 GLU A 210 LYS A 221 1 12 HELIX 11 AB2 PRO A 232 TRP A 243 1 12 HELIX 12 AB3 ASP A 246 ARG A 250 5 5 HELIX 13 AB4 SER A 252 ASP A 266 1 15 HELIX 14 AB5 SER A 268 ASN A 279 1 12 HELIX 15 AB6 ASN A 279 LYS A 296 1 18 SHEET 1 AA1 5 LEU A 16 CYS A 22A 0 SHEET 2 AA1 5 VAL A 30 TRP A 35 -1 O VAL A 30 N CYS A 22A SHEET 3 AA1 5 LYS A 40 LEU A 47 -1 O VAL A 42 N ALA A 33 SHEET 4 AA1 5 ASN A 77 GLU A 83 -1 O TYR A 78 N LEU A 47 SHEET 5 AA1 5 PHE A 68 GLU A 74 -1 N GLU A 74 O ASN A 77 SHEET 1 AA2 2 VAL A 139 ILE A 141 0 SHEET 2 AA2 2 LEU A 147 ILE A 149 -1 O LYS A 148 N VAL A 140 LINK SG ACYS A 22A C32AIGV A 401 1555 1555 1.80 LINK SG BCYS A 22A C32BIGV A 401 1555 1555 1.81 CISPEP 1 PRO A 75 PRO A 76 0 6.09 CRYST1 129.976 48.608 42.881 90.00 105.78 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007694 0.000000 0.002174 0.00000 SCALE2 0.000000 0.020573 0.000000 0.00000 SCALE3 0.000000 0.000000 0.024233 0.00000